Table 1.
Confirmed and new biological activities of azo compounds (1–10) derived from actinomycetes
| No. | Activity reviewed | Activities confirmed (Pa) | Additional predicted activities (Paa) |
|---|---|---|---|
| 1 | Antibiotic antineoplastic | Antineoplastic (0.985) Antineoplastic antibiotic (0.848) |
Phobic disorders treatment (0.819) Hepatic disorders treatment (0.662) |
| 2 | Not studied | – | Antineoplastic (0.880) Phobic disorders treatment (0.864) Hepatic disorders treatment (0.852) |
| 3 | Not studied | – | Phobic disorders treatment (0.907) Antiseborrheic (0.861) Antineoplastic (0.862) |
| 4 | Antibiotic | – | Hepatic disorders treatment (0.872) Antineoplastic (0.736) Antieczematic (0.733) |
| 5 | Antibiotic | Antibacterial (0.507) | Hepatic disorders treatment (0.819) Antiviral (arbovirus) (0.783) Antineoplastic (0.746) |
| 6 | Antibiotic | Antibacterial (0.527) | Hepatic disorders treatment (0.765) Antineoplastic (0.760) Antifungal (0.653) |
| 7 | Antibiotic antifungal | Antifungal (0.640) | Hepatic disorders treatment (0.778) Antineoplastic (0.763) Antieczematic (0.717) |
| 8 | Antibiotic antifungal | – | Phobic disorders treatment (0.860) Mucositis treatment (0.765) Antiviral (arbovirus) (0.747) |
| 9 | Antifungal | Antifungal (0.658) | Hepatic disorders treatment (0.793) Antiviral (arbovirus) (0.771) Antineoplastic (0.779) |
| 10 | Antifungal | Antifungal (0.632) | Hepatic disorders treatment (0.819) Antiviral (arbovirus) (0.783) Antineoplastic (0.746) |
aOnly activities with Pa > 0.5 are shown